Clinical Trial Update: A Phase I Clinical Trial Immunizing Healthy Adults With the NMRC-M3V-Ad-PfCA Vaccine to Generate Biologic Reagents [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of the NMRC-M3V-Ad-PfCA vaccine in healthy adults for malaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• NMRC-M3V-Ad-PfCA

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Healthy, Malaria | Phase 1 | Status: WITHDRAWN